Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.25
Delayed Data
As of 3:59pm ET
 +0.09 / +2.85%
Today’s Change
2.28
Today|||52-Week Range
7.46
-29.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.003.2M
 
 
Depreciation And Amortization331.0K353.0K344.0K285.0K
 
 
 
 
 
 
Operating ExpensesGross Income-331.0K-353.0K-344.0K--
 
 
 
 
General Expenses55.6M27.9M28.1M40.8M
 
 
 
 
 
Research And Development49.2M21.7M21.8M33.5M
 
 
 
 
 
Total Operating Expenses55.9M28.2M28.5M41.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-55.9M-28.2M-28.5M-37.9M
 
 
 
 
 
Interest Expense On Debt3.4M2.6M1.0M0.00
 
 
 
 
Other Expenses-111.0K-15.0K-96.0K2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-59.4M-30.9M-29.6M-35.2M
 
 
 
 
 
Net Income-59.4M-30.9M-29.6M-35.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.2M18.3M21.8M35.6M
 
 
 
 
 
Shares To Calculate EPS Diluted7.2M18.3M21.8M35.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.24-$1.69-$1.36-$0.99
 
 
 
 
 
EPS Diluted-$8.24-$1.69-$1.36-$0.99